| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V32286 | (E)-4-Hydroxytamoxifen | 174592-47-3 | (E)-4-Hydroxytamoxifen (Afimoxifene) is the less active isomer of 4-Hydroxytamoxifen. |
|
V33403 | (E)-Alprenoxime | 125720-84-5 | (E)-Alprenoxime is an enantiomer of Alprenoxime. |
|
V39098 | (E)-Cinnamamide | 22031-64-7 | (E)-Cinnamamide is a less active isomer of Cinnamamide. |
|
V38228 | (E)-Crotylbarbital | 28360-89-6 | (E)-Crotylbarbital is an enantiomer of Crotylbarbital. |
|
V31253 | (E)-Ethyl p-methoxycinnamate | 24393-56-4 | (E)-Ethyl p-methoxycinnamate is a naturally occurring compound found in Kaempferia galangal and has anti~inflammatory, anti-tumor and anti-microbial effects. |
|
V30685 | (E)-Flavokawain A | 37951-13-6 | (E)-Flavokawain A is a chalcone found in kava and has anticancer properties. |
|
V39030 | (E)-Ligustilide | 81944-08-3 | (E)-Ligustilide is extracted from Angelica sinensis and has renal protective effects. |
|
V32753 | (E)-m-Coumaric acid | 14755-02-3 | (E)-m-Coumaric acid (3-Hydroxycinnamic acid) is an aromatic acid abundant in food. |
|
V40644 | (E/Z)-BCI | 15982-84-0 | (E/Z)-BCI (NSC 150117) is a DUSP6 inhibitor (antagonist) with anti~inflammatory activity. |
|
V38459 | (E/Z)-GSK5182 | 1936468-29-9 | (E/Z)-GSK5182 is a racemic mixture of (E)-GSK5182 and (Z)-GSK5182 configurational isomers. |
|
V38547 | (Ethoxymethyl)benzene | 539-30-0 | (Ethoxymethyl)benzene is an endogenously produced metabolite. |
|
V37876 | (R)-(+)-Anatabine | 126454-22-6 | (R)-(+)-Anatabine is a less active S-isomer of Anatabine. |
|
V31273 | (R)-(+)-Citronellal | 2385-77-5 | (R)-(+)-Citronellal can be extracted from citrus, lavender and eucalyptus oils. |
|
V38854 | (R)-(+)-HA-966 | 123931-04-4 | (R)-(+)-HA-966 ((+)-HA-966) is a partial agonist/antagonist at the glycine site of the N-methyl-D-aspartate (NMDA) receptor complex . |
|
V38813 | (R)-(-)-α-Methylhistamine dihydrobromide | 868698-49-1 | (R)-(-)-α-Methylhistamine diHBr is a potent, selective and BBB (blood-brain barrier) permeable/penetrable H3 histamine receptor agonist (activator) with Kd of 50.3 nM. |
|
V34085 | (R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid | 103733-65-9 | (R)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylic acid is a Phe analog. |
|
V39016 | (R)-3-Hydroxy Midostaurin | 155848-20-7 | (R)-3-Hydroxy Midostaurin [also known as(R)-CGP-52421; (R)-CGP52421] is a minor metabolite of midostaurin, whichis amultiple kinase inhibitor andan anticancer drug approved in 2017 by FDA to treat acute myeloid leukemia. |
|
V32054 | (R)-3-Hydroxyisobutyric acid | 1910-47-0 | (R)-3-Hydroxyisobutyric acid is a novel and potent intermediate in the pathways of l-valine and thymine |
|
V40305 | (R)-Apremilast D5 | R)-Apremilast D5 is the penta-deuterated form of (R)-Apremilastwhichis PDE-4 inhibitor used for the treatment of psoriatic arthritis. | |
|
V37741 | (R)-BMS-816336 | 1009583-83-8 | (R)-BMS-816336 (Compound 6n-1) is a potent orally bioactive human, mouse and cynomolgus monkey 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor (antagonist) with IC50 of 14.5, respectively. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
